An Enhanced Recovery after Surgery Pathway for Microvascular Breast Reconstruction Is Safe and Effective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An Enhanced Recovery after Surgery Pathway for Microvascular Breast Reconstruction Is Safe and Effective

Published:2018-01 Issue:1 Volume:6 Page:e1634
ISSN:2169-7574
Container-title:Plastic and Reconstructive Surgery - Global Open
language:en
Short-container-title:Plastic and Reconstructive Surgery - Global Open

Author:

Astanehe Arezoo,Temple-Oberle Claire,Nielsen Markus,de Haas William,Lindsay Robert,Matthews Jennifer,McKenzie David C,Yeung Justin,Schrag Christiaan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery,Surgery

Reference37 articles.

1. What is a clinical pathway? Development of a definition to inform the debate

2. The Impact of Clinical Pathways on the Practice of Head and Neck Oncologic Surgery

3. Implementation and Evaluation of a Clinical Pathway for TRAM Breast Reconstruction

4. Processes of Care in Autogenous Breast Reconstruction with Pedicled TRAM Flaps

5. Enhanced recovery after surgery in microvascular breast reconstruction

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The first 150 consecutive DIEP free flaps: Lessons learnt and a guide to efficiency for the junior plastic surgeon;JPRAS Open;2024-09

2. Enhanced Recovery After Gender-Affirming Surgery;Aesthetic Surgery Journal;2024-08-16

3. Impact of Gabapentin on Postoperative Hypotension in Enhanced Recovery after Surgery Protocols for Microvascular Breast Reconstruction;Plastic and Reconstructive Surgery - Global Open;2024-04

4. Acceptance of outpatient enhanced recovery after surgery (ERAS©) protocols for implant-based breast reconstruction nudged on by the COVID-19 pandemic;The Breast;2024-04

5. Enhanced Recovery After Surgery in Immediate DIEP Flap Breast Reconstruction: Reducing Length of Stay and Opioid Use;Plastic Surgery;2024-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3